vTv Therapeutics
(NASDAQ:VTVT)
$24.13
-0.11[-0.45%]
At close: Apr 16
$24.00
-0.1300[-0.54%]
After Hours: 6:08PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary

vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.

Open$25.000
Close$24.130
Volume / Avg.5.229K / 74.316K
Day Range24.130 - 25.000
52 Wk Range7.380 - 39.600
Market Cap$58.705M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
58
Short Interest
2.15%
Days to Cover1.12

Recent News

S&P 500 Edges Lower; ADT Posts Upbeat Earnings
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92.
Avi Kapoor
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Avi Kapoor
Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?
vTv Therapeutics stock surge, fueled by a $51M private placement. Learn about their clinical-stage biopharmaceutical focus on cadisegliatin for type 1 diabetes. Stock up 111.8% at $18.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About vTv Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of ora...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VTVT
KZR

FAQ

Q

How do I buy vTv Therapeutics (VTVT) stock?

A

You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are vTv Therapeutics's (VTVT) competitors?

A

Other companies in vTv Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).

Q

What is the target price for vTv Therapeutics (VTVT) stock?

A

The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to fall to within 12 months (a possible -75.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for vTv Therapeutics (VTVT)?

A

The stock price for vTv Therapeutics (NASDAQ: VTVT) is $24 last updated April 12, 2024 at 6:08 PM EDT.

Q

Does vTv Therapeutics (VTVT) pay a dividend?

A

There are no upcoming dividends for vTv Therapeutics.

Q

When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?

A

vTv Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is vTv Therapeutics (VTVT) going to split?

A

There is no upcoming split for vTv Therapeutics.

Q

What sector and industry does vTv Therapeutics (VTVT) operate in?

A

vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch